English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Neurocytoma was first described by Hassoun et al.[1] in 1982. It is a rare brain tumor characterized by typical ultrastructural neuronal differentiation and immunohistochemical profile. Neurocytoma comprises approximately 1% of all brain tumors. It is most often seen in young adults, with obvious peaks in second and third decades of life.[2–5] Neurocytoma is described as a benign grade II tumor by World Health Organization (WHO). It is typically located deep midline or even in supratentorial region, as well as in septum pellicidum, fornices, or lateral ventricles.[2,3,5,6] Symptoms due to increased intracranial pressure and obstructive hydrocephalus are generally present. Symptoms such as headache, nausea, vomiting, and visual disturbances are seen in the last few months.[2,3,5,7] Neurocytoma is differentiated into 2 main subgroups: Typical neurocytomas account for 75% (benign lesion with high grade cellular differentiation and low mitotic activity), and atypical neurocytomas make

Different Central Localizations, Different Histopathologies, Benefits, and Side Effects of Radiotherapy in Neurocytoma